The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Flaum Sander A since 2007.
The trader's CIK number is 1261026.
At the time of the last reporting, Flaum Sander A was the Director of Eagle Pharmaceuticals, Inc.. (stock ticker symbol EGRX).
Also see all insider trading activities at Eagle Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2019 | EGRX | 0 | $0 | 0 | $0 | 2,340 | $9,453 |
| 2018 | EGRX | 0 | $0 | 2,340 | $126,219 | 2,340 | $2,106 |
| 2016 | EGRX | 0 | $0 | 5,000 | $393,300 | 0 | $0 |
| 2015 | EGRX | 0 | $0 | 13,025 | $713,959 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2007 | VAS | 0 | $0 | 0 | $0 | 8,088 | $180,168 |
1. Eagle Pharmaceuticals, Inc. (EGRX)
2. Viasys Healthcare Inc (VAS)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2019-03-05 | EGRX | Option Ex | 2,340 | 4.04 | 9,453 |
| 2018-03-06 | EGRX | Sale | 2,340 | 53.94 | 126,219 |
| 2018-03-05 | EGRX | Option Ex | 2,340 | .90 | 2,106 |
| 2016-11-28 | EGRX | Sale | 5,000 | 78.66 | 393,300 |
| 2015-03-20 | EGRX | Sale | 9,800 | 42.00 | 411,600 |
| 2015-12-22 | EGRX | Sale | 3,225 | 93.75 | 302,359 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2007-06-28 | VAS | Option Ex | 8,088 | 22.28 | 180,168 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Flaum Sander A (Director of Eagle Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.